MediScan secures $1.4M to bring "Prescription- Strength AI" firepower to the Medical-Legal frontline for $16B medical claims market

Friday, June 27, 2025 | 576 | 0

Seattle, USA: MediScan AI has secured $1.4 million in funding, led by Vertical AI investor Tidal Ventures, to tackle one of healthcare's most overlooked bottlenecks the medical evaluation process that determines the outcome of millions of insurance and legal claims annually.

In an industry where medical experts are drowning in paperwork and turning away cases, MediScan's AI platform has already demonstrated the ability to reduce evaluation time from weeks to minutes per case while improving accuracy.

"Growing up with my father working as an independent medical evaluator, I witnessed firsthand the challenges and inefficiencies in the process,"
-Kavian Mojabe, CEO and Co-founder of MediScan

The company's technology resonates with physician-evaluators, who have processed over 14,000 cases through the platform. With high customer retention, MediScan has quickly captured early market share in what industry experts estimate is a multi-billion dollar opportunity.

"We've built what we call 'physician-grade AI' through our proprietary Reinforcement Learning from Evaluator Feedback system. Every interaction between a physician and our platform further refines our models to think like a medical expert."
-Sean Podvent, COO and Co-founder

Unlike broad legal AI companies, MediScan has carved out a focused niche at the intersection of medicine, insurance, and law-domains where general-purpose AI tools fall short.

Rather than relying on narrow, operationally expensive internal QA, MediScan trains its models on real-world edits from a diverse range of physicians across specialties, regions, and practice styles. This diversity creates a clinically grounded dataset that reflects real-world medical interpretation.

"As a Qualified Medical Examiner in the state of California, I rely heavily on accurate, efficient, and comprehensive medical record review. MediScan AI has consistently exceeded my expectations."
-Dr. Steven Scribner, D.O.

"What caught our attention was MediScan's razor-sharp focus on an underserved market essential to our insurance and legal systems. Their technology is already making a critical difference at scale."
-Nicholas Muy, Venture Partner at Tidal Ventures

The capital will accelerate product development and enhance MediScan's AI capabilities. The company will also expand its engineering and sales teams to meet growing demand.

"We're just scratching the surface of what's possible. About 20% of our users are personal injury and malpractice lawyers who discovered our platform delivers better results than legal-specific AI tools."
-Kavian Mojabe

About MediScan

Founded in 2024, MediScan AI is revolutionizing medical evaluation through AI-powered document analysis and workflow tools. The platform enables medical experts to process complex records efficiently, generating comprehensive reports for legal and insurance purposes. MediScan's proprietary AI improves continuously through real physician feedback.

About Tidal Ventures

Tidal Ventures partners with disruptive early-stage B2B SaaS companies to revolutionize industries. Their hands-on approach helps 70% of their portfolio secure follow-on funding, offering capital and strategic support at every stage.